Table 3.
Comparing between the CONUT score low (< 2) and high (≥ 2) patients.
| Total(n = 266) | Conut < 2(n = 146) | Conut ≥ 2(n = 120) | p | ||
|---|---|---|---|---|---|
| Age | < 65 | 136 (51.1%) | 87 | 49 | p = 0.002 |
| ≥ 65 | 130 (48.9%) | 59 | 71 | ||
| Sex | Female | 131 (49.3%) | 67 | 64 | p = 0.227 |
| Male | 135 (50.7%) | 79 | 56 | ||
| ECOG | < 1 | 158 (59.4%) | 105 | 43 | p = 0.001 |
| ≥ 1 | 108 (40.6%) | 41 | 67 | ||
| LDH | normal | 136 (51.1%) | 91 | 45 | p = 0.001 |
| > normal | 130 (48.9%) | 55 | 75 | ||
| Bone marrow involvement | - | 217 (81.6%) | 137 | 80 | p = 0.001 |
| + | 49 (18.4%) | 9 | 40 | ||
| Extranodal Disease | - | 133 (50%) | 93 | 40 | p = 0.001 |
| + | 133 (50%) | 53 | 80 | ||
| Stage | IA-IIB | 159 (59.8%) | 114 | 45 | p = 0.001 |
| IIIA-IVB | 107 (40.2%) | 32 | 75 | ||
| IPI (low,low intermediate) | 167 (62.8%) | 129 | 38 | p = 0.001 | |
| IPI (high intermediate,high) | 99 (37.2%) | 17 | 82 | ||